MEDFITNESS

With the continuing increase in standard of living, the focus on quality of life has amplified in recent times. In particular, obesity is a health issue featured in the mass media that has been warranting more attention than ever before. More and more people are coming to realize that obesity is at the root of all habitual illnesses, and because of this coorelation interest in obesity treatment is on the rise. Biospace’s body composition analyzer, InBody stands at the center of this anti-obesity movement.

Up until recently, most people believed that obesity could be precluded by simply losing a certain number of kilograms in body weight. However, with the development of the InBody, Biospace has made the terms „body composition” and „body fat” popular, and has spread the knowledge that the prevention of obesity hinges on the reduction and control of body fat. Biospace’s trailblazing activities in this area are evident in the label of „InBody test”, acommonly given body composition analysis that has recently increased in popularity.

InBody made by Biospace, is the world’s first body composition analysis device that uses the 8-point tactile electrode method. Having received FDA approval in the United States and approval of other countries’authorities, such as in Japan, this product’s high quality and accuracy has been validated.

With the unparalleled performance of the InBody in the domestic obesity diagnosis market Biospace has solidified its foundation as a professional medical device manufacturer. The plan for the future entails the company’s on going development and expansion into a comprehensive professional health care organization.

In particular, the company is striving to achieve superior competitiveness that will facilitate success in advanced markets around the world, such as those in the United States, Japan and Europe.